NASDAQ · CHEMICALS & ALLIED PRODUCTS · SMALL CAP
Solstice Advanced Materials Inc. SOLS
3 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$3.9B
▲ 3.1% vs FY2024
EPS · FY25
$1.49
Dividend / sh · FY25
—
Payout · FY25
633%
ROE · FY25
10.2%
Net margin · FY25
6.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.9B
Revenue, FY2025 · full 3-year series below
Revenue
Net income
6 cents of every revenue dollar became profit this year.
Per share
USD 1.49
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
10.2%
Return on equity, FY2025
ROE
Operating margin16.6%
Net margin6.1%
Return on assets4.4%
Each USD of equity produced 10 cents of profit this year.
Returned to shareholders
USD 1.5B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 1.5B
Net buybacks—
Share of profit632.9%
Consecutive raises—
USD 1.5B in dividends — 633% of the year's profit, so the payout drew on cash built up earlier.
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.16B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 5.7B
total assets, end of FY2025
Total assetsUSD 5.7B
EquityUSD 1.4B
CashUSD 534.0M
Gross debtUSD 2.0B
Net debtUSD 1.4B
Current ratio1.39×
Net debt stands at 102% of equity.
History
3 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
Revenue $B
3.9
3.8
3.6
Operating income $B
0.6
0.8
0.8
EBITDA $B
0.7
0.8
0.9
Income tax $B
0.4
0.2
0.2
Net income $B
0.2
0.6
0.6
EPS, diluted $
1.49
3.74
3.91
Dividend / sh $
·
·
·
Payout %
633
0
0
ROE %
10.2
18.2
·
Shares out B
0.16
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
7 of 7
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed